HR 5372 · 118th Congress · Health

Expanding Seniors' Access to Lower Cost Medicines Act of 2023

Introduced 2023-09-08· Sponsored by Rep. Joyce, John [R-PA-13]· House

Bill Progress

Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.(2023-12-06)

Plain Language Summary

[AI summary unavailable — showing source text] [Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [H.R. 5372 Introduced in House (IH)] <DOC> 118th CONGRESS 1st Session H. R. 5372 To amend Title XVIII of the Social Security Act to facilitate midyear formulary changes for biosimilars. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES September 8, 2023 Mr. Joyce of Pennsylvania (for himself and Mr. Peters) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned _______________________________________________________________________ A BILL To amend Title XVIII of the Social Security Act to facilitate midyear formulary changes for biosimilars. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Expanding Seniors' Access to Lower Cost Medicines Act of 2023''. SEC. 2. FACILITATING M…

Summarized by Claude AI · Non-partisan · For informational purposes only

CBO Cost Estimate

Congressional Budget Office

H.R. 5372, Expanding Seniors’ Access to Lower Cost Medications Act of 2023

Mar 13, 2024

As ordered reported by the House Committee on Energy and Commerce on December 6, 2023

Full CBO report ↗

Official non-partisan budget analysis by the Congressional Budget Office

Cosponsors (1)

1 Democrat